Research ArticleHuman Studies
Dose Fractionation of Radiolabeled Antibodies in Patients with Metastatic Colon Cancer
Ruby F. Meredith, M.B. Khazaeli, Tiepu Liu, Gene Plott, Richard H. Wheeler, Charles Russell, David Colcher, Jeffrey Schlom, Dan Shochat and Albert F. LoBuglio
Journal of Nuclear Medicine September 1992, 33 (9) 1648-1653;
Ruby F. Meredith
M.B. Khazaeli
Tiepu Liu
Gene Plott
Richard H. Wheeler
Charles Russell
David Colcher
Jeffrey Schlom
Dan Shochat
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Dose Fractionation of Radiolabeled Antibodies in Patients with Metastatic Colon Cancer
Ruby F. Meredith, M.B. Khazaeli, Tiepu Liu, Gene Plott, Richard H. Wheeler, Charles Russell, David Colcher, Jeffrey Schlom, Dan Shochat, Albert F. LoBuglio
Journal of Nuclear Medicine Sep 1992, 33 (9) 1648-1653;
Jump to section
Related Articles
- No related articles found.
Cited By...
- A Method to Correct for Radioactivity in Large Vessels That Overlap the Spine in Imaging-Based Marrow Dosimetry of Lumbar Vertebrae
- High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody
- A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer
- Targeted Therapy of Cancer with Radiolabeled Antibodies
- Single-Dose versus Fractionated Radioimmunotherapy of Human Colon Carcinoma Xenografts Using 131I-labeled Multivalent CC49 Single-chain Fvs
- Intratumoral Distribution of Two Consecutive Injections of Chimeric Antibody G250 in Primary Renal Cell Carcinoma: Implications for Fractionated Dose Radioimmunotherapy